HER2+ and TNBC are more likely to be infiltrated by tumor-infiltrating lymphocytes (TILs) and to express programmed death ligand-1 (PD-L1) in the TME than ER- or PR-expressing luminal tumors (93–95). Here, ERBB2 is linked to neoplasm.